336 related articles for article (PubMed ID: 22464730)
41. Protein interactions in the sumoylation cascade: lessons from X-ray structures.
Tang Z; Hecker CM; Scheschonka A; Betz H
FEBS J; 2008 Jun; 275(12):3003-15. PubMed ID: 18492068
[TBL] [Abstract][Full Text] [Related]
42. Lysine activation and functional analysis of E2-mediated conjugation in the SUMO pathway.
Yunus AA; Lima CD
Nat Struct Mol Biol; 2006 Jun; 13(6):491-9. PubMed ID: 16732283
[TBL] [Abstract][Full Text] [Related]
43. Structure and analysis of a complex between SUMO and Ubc9 illustrates features of a conserved E2-Ubl interaction.
Capili AD; Lima CD
J Mol Biol; 2007 Jun; 369(3):608-18. PubMed ID: 17466333
[TBL] [Abstract][Full Text] [Related]
44. Regulation of Wnt signaling by the nuclear pore complex.
Shitashige M; Satow R; Honda K; Ono M; Hirohashi S; Yamada T
Gastroenterology; 2008 Jun; 134(7):1961-71, 1971.e1-4. PubMed ID: 18439914
[TBL] [Abstract][Full Text] [Related]
45. A new clue at the nuclear pore: RanBP2 is an E3 enzyme for SUMO1.
Azuma Y; Dasso M
Dev Cell; 2002 Feb; 2(2):130-1. PubMed ID: 11832237
[TBL] [Abstract][Full Text] [Related]
46. Structural insights into the regulation of the human E2∼SUMO conjugate through analysis of its stable mimetic.
Goffinont S; Coste F; Prieu-Serandon P; Mance L; Gaudon V; Garnier N; Castaing B; Suskiewicz MJ
J Biol Chem; 2023 Jul; 299(7):104870. PubMed ID: 37247759
[TBL] [Abstract][Full Text] [Related]
47. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
[TBL] [Abstract][Full Text] [Related]
48. A Fluorescent In Vitro Assay to Investigate Paralog-Specific SUMO Conjugation.
Eisenhardt N; Chaugule VK; Pichler A
Methods Mol Biol; 2016; 1475():67-78. PubMed ID: 27631798
[TBL] [Abstract][Full Text] [Related]
49. SIM-dependent enhancement of substrate-specific SUMOylation by a ubiquitin ligase in vitro.
Parker JL; Ulrich HD
Biochem J; 2014 Feb; 457(3):435-40. PubMed ID: 24224485
[TBL] [Abstract][Full Text] [Related]
50. Mel-18 interacts with RanGAP1 and inhibits its sumoylation.
Zhang J; Sarge KD
Biochem Biophys Res Commun; 2008 Oct; 375(2):252-5. PubMed ID: 18706886
[TBL] [Abstract][Full Text] [Related]
51. RanBP2 associates with Ubc9p and a modified form of RanGAP1.
Saitoh H; Pu R; Cavenagh M; Dasso M
Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3736-41. PubMed ID: 9108047
[TBL] [Abstract][Full Text] [Related]
52. Ubc9 sumoylation regulates SUMO target discrimination.
Knipscheer P; Flotho A; Klug H; Olsen JV; van Dijk WJ; Fish A; Johnson ES; Mann M; Sixma TK; Pichler A
Mol Cell; 2008 Aug; 31(3):371-82. PubMed ID: 18691969
[TBL] [Abstract][Full Text] [Related]
53. Opposing biological functions of the cytoplasm and nucleus DAXX modified by SUMO-2/3 in gastric cancer.
Chen C; Sun X; Xie W; Chen S; Hu Y; Xing D; Xu J; Chen X; Zhao Z; Han Z; Xue X; Shen X; Lin K
Cell Death Dis; 2020 Jul; 11(7):514. PubMed ID: 32641734
[TBL] [Abstract][Full Text] [Related]
54. Recombinant reconstitution of sumoylation reactions in vitro.
Flotho A; Werner A; Winter T; Frank AS; Ehret H; Melchior F
Methods Mol Biol; 2012; 832():93-110. PubMed ID: 22350878
[TBL] [Abstract][Full Text] [Related]
55. Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.
Dawlaty MM; Malureanu L; Jeganathan KB; Kao E; Sustmann C; Tahk S; Shuai K; Grosschedl R; van Deursen JM
Cell; 2008 Apr; 133(1):103-15. PubMed ID: 18394993
[TBL] [Abstract][Full Text] [Related]
56. ATPase-dependent control of the Mms21 SUMO ligase during DNA repair.
Bermúdez-López M; Pociño-Merino I; Sánchez H; Bueno A; Guasch C; Almedawar S; Bru-Virgili S; Garí E; Wyman C; Reverter D; Colomina N; Torres-Rosell J
PLoS Biol; 2015 Mar; 13(3):e1002089. PubMed ID: 25764370
[TBL] [Abstract][Full Text] [Related]
57. Comparative analysis of yeast PIAS-type SUMO ligases in vivo and in vitro.
Takahashi Y; Toh-E A; Kikuchi Y
J Biochem; 2003 Apr; 133(4):415-22. PubMed ID: 12761287
[TBL] [Abstract][Full Text] [Related]
58. RanBP2 and SENP3 function in a mitotic SUMO2/3 conjugation-deconjugation cycle on Borealin.
Klein UR; Haindl M; Nigg EA; Muller S
Mol Biol Cell; 2009 Jan; 20(1):410-8. PubMed ID: 18946085
[TBL] [Abstract][Full Text] [Related]
59. Sumoylation delays the ATF7 transcription factor subcellular localization and inhibits its transcriptional activity.
Hamard PJ; Boyer-Guittaut M; Camuzeaux B; Dujardin D; Hauss C; Oelgeschläger T; Vigneron M; Kedinger C; Chatton B
Nucleic Acids Res; 2007; 35(4):1134-44. PubMed ID: 17264123
[TBL] [Abstract][Full Text] [Related]
60. Modification of Ran GTPase-activating protein by the small ubiquitin-related modifier SUMO-1 requires Ubc9, an E2-type ubiquitin-conjugating enzyme homologue.
Lee GW; Melchior F; Matunis MJ; Mahajan R; Tian Q; Anderson P
J Biol Chem; 1998 Mar; 273(11):6503-7. PubMed ID: 9497385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
